Cmed Clinical Services is a global CRO providing services to the Biopharma industry worldwide. Cmed was established in 2000 with the vision to conduct clinical trials better than anyone else, thus saving and helping lives. Cmed works with clients to not only deliver the clinical trial services effectively, and with quality, passion, teamwork and superior customer service, but also, especially for full service projects, by understanding the clients commercial and business objectives. Cmed then leverages its in-depth expertise to ensure the development program and/or clinical trial is well designed and conducted as efficiently and as cost effectively as possible. Cmed has particular expertise in the design and conduct of complex, oncology and rare disease trials and the provision of Biometric functional services.
Company Growth (employees)
Type
Private
HQ
West Sussex, GB
Founded
1999
Size (employees)
334 (est)
Cmed was founded in 1999 and is headquartered in West Sussex, GB

Key People at Cmed

David Connelly

David Connelly

Chief Executive Officer
Timothy Corbett-Clark

Timothy Corbett-Clark

Chief Technical Officer
Gareth Hughes

Gareth Hughes

Chief Officer Corporate Business Management
Andrew Griffiths

Andrew Griffiths

Chief Operations Officer
Alan Eggleston

Alan Eggleston

Global Head Marketing and Sales

Cmed Office Locations

Cmed has offices in West Sussex, Durham, Cambridge, Sânnicolau Mare and in 1 other location
West Sussex, GB (HQ)
Holmwood - Broadlands Business Campus Langhurstwood Road Horsham
San Bruno, US
001 Bayhill Dr. Second Floor San Bruno, CA 94066
Sânnicolau Mare, RO
Str. Coriolan Brediceanu, Nr. 10 City Business Centre Building A, Second Floor Timisoara 300011
Cambridge, US
485 Massachusetts Avenue
Durham, US
Maplewood Building 4620 Creekstone Drive, Suite 160

Cmed Data and Metrics

Summary Metrics

Founding Date

1999

Total Funding

$11.5 m

Latest funding size

$5 m

Time since last funding

over 8 years

Investors

Cmed's latest funding round in November 2008 was reported to be $5 m. In total, Cmed has raised $11.5 m

Cmed Financial Metrics

Cmed's revenue was reported to be £2.2 m in FY, 2015 which is a 6% decrease from the previous period.
GBP

Revenue (FY, 2015)

2.2 m

Revenue growth (FY, 2014 - FY, 2015), %

(6%)

Gross profit (FY, 2015)

1.8 m

Gross profit margin (FY, 2015), %

81%

Net income (FY, 2015)

501 k

Cash (31-Dec-2015)

5 k
GBPFY, 2013FY, 2014FY, 2015

Revenue

2.5 m2.4 m2.2 m

Revenue growth, %

(5%)(6%)

Cost of goods sold

630 k468 k429 k

Gross profit

1.9 m1.9 m1.8 m

Gross profit Margin, %

75%80%81%

Pre tax profit

(242 k)154 k430 k

Net Income

(80 k)280 k501 k
GBPFY, 2013FY, 2014FY, 2015

Cash

5 k5 k5 k

Accounts Receivable

23 k22 k

Current Assets

747 k1.3 m258 k

PP&E

88 k56 k28 k

Total Assets

835 k1.4 m286 k

Accounts Payable

35 k43 k48 k

Current Liabilities

9.5 m9.8 m8.2 m

Total Liabilities

9.5 m9.8 m8.2 m

Retained Earnings

(80 k)280 k501 k

Total Equity

(8.7 m)(8.4 m)(7.9 m)

Financial Leverage

-0.1 x-0.2 x0 x
GBPFY, 2013FY, 2014FY, 2015

Income Taxes Paid

162 k126 k71 k
GBPY, 2015

Revenue/Employee

7.6 k

Traffic Overview of Cmed

Cmed Company Life and Culture

You may also be interested in